Veterinary POC Diagnostic Market Share accelerating a CAGR during the forecast period

Veterinary POC Diagnostic Market-Overview

Medical progress has led to advancements in the veterinary healthcare system, such as Point-of-Care (PoC), which permits speedy results in non-laboratory situations. According to an MRFR report, the market will earn USD 1.285 Billion by 2030 and will gain a CAGR of 9.70% during the forecast year 2022- 2030.

Accelerating pandemic illnesses such as swine flu and rabies will further promote the market. Less time spent on testing and outcomes, more precise results, a shift in diagnostic trends, and the adoption of cutting-edge technologies is likely to fuel the veterinary Point-of-Care (PoC) diagnostic market share.

Segmental Analysis

The segmental study of the veterinary POC diagnostic market outlook has been conducted based on the technology, application, product, animal type, and end user. The market based on end users has been segmented into hospitals & clinics and home care. The market has been segmented into companion animals and livestock animals based on the animal type. The veterinary POC diagnostic market has been segmented into consumables and instruments based on the type. The market has been segmented into immunodiagnostics, urinalysis, clinical biochemistry, hematology, and molecular diagnostics based on technology. The market has been segmented into orthopedics & traumatology, virology, clinical pathologyoncology, parasitology, gynecology, cardiology, bacteriology, and neurology based on the application.

Competitive Analysis

The reliance on online commerce for sales is expected to increase significantly during the forecast period, prompting market stakeholders to invest more in its growth. Due to the return of COVID cases in many locations, the market may exhibit constrained growth. The continuation of occasional lockdowns in numerous regions may cause the market expansion to be hampered if resources such as labor and supply chains are severely impacted. The global market is expected to diversify in operational techniques as innovative models for operation and delivery are implemented. It is projected that the emphasis on accumulating reserves of resources to deal with unexpected crises would impact future market trends. Government assistance is expected to support worldwide market development in the next years. Market developments and research are expected to generate attractive growth opportunities in the next years.

The prominent companies in the veterinary POC diagnostic market player are Idexx Laboratories, Inc. (US), Woodley Equipment Company Ltd. (UK), Zoetis, Inc. (US), Virbac (France), Thermo Fisher Scientific, Inc. (US), Eurolyser Diagnostica GmbH (Austria), Minxray, Inc. (US), AniPoC, Ltd. (UK), Neurologica Corporation (US), Fujifilm Sonosite, Inc. (Japan), Carestream Health, Inc. (US), Diagnostic Imaging Systems, Inc. (US), Esaote spa (Italy), Mindray Medical International Limited (A Part of Excelsior Union Limited) (China), Heska Corporation (US), Randox Laboratories, Ltd. (UK), GE Healthcare (US), QR s.r.l. (Italy), Sedecal (Spain), and Examion GmbH (Germany).

Detailed Regional Analysis 

In the forecast period, the North American market generated outstanding revenue. The growing adoption of pet animals for companionship, coupled with the high animal healthcare expenditure, will boost the North American veterinary POC diagnostic market insights. Advances in veterinary diagnostics and multiple laboratories in the region applying innovative molecular diagnostic techniques will propel market expansion even further. The European market will grow at a 7.8 percent annual rate during the predicted period. The collective need for animal products and an increasing emphasis on biologicals, which aids in the development of various vaccines, are driving the rise of the animal diagnostics business in Europe. Elevated animal food consumption puts strain on animal farms, increasing demand for animal diagnostics to reduce the spread of zoonotic and animal foodborne diseases. The Asia-Pacific region is expected to grow at the quickest rate throughout the forecast period, owing to the rapid development of manufacturing facilities in developing economies such as China and India.

About US:

Market Research Future (MRFR) enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

Biologic Therapy Market Outlook, Trends, Size and Forecast To 2030

Global Biologic Therapy Market to Grow Healthily over 2023

Biologic therapy is gaining traction. According to a report published by Market Research Future (MRFR), the global biologic therapy market share is set to reach USD 288.03 billion by 2030 at a CAGR 8.20% over the forecast years 2023-2030. Biologic therapy is viewed as an innovative treatment module based on products sourced from living organisms.

Biologic therapy is used to stimulate or suppress the immune system for treatment purposes. The therapy finds application in treatment of diseases such as infection, cancer and several other diseases. Advances in the field of biologic therapeutic is boosting the application scope of biologic therapy. Rising demand for biological and targeted drug therapies is making a positive impact on the global biological therapy market. The R&D pipeline for biologic therapy is expected to grow in the future as pharmaceutical companies realise the vast market opportunities. 

Global Biologic Therapy Market: Regional Analysis

On the basis of region, the biologic therapy market insights has been segmented into North America, Europe, the Middle East & Africa (MEA), Latin America and Asia Pacific (APAC). North America represents an important market for biologic therapy. Rising geriatric population, growing cancer prevalence in countries such as the U.S. and Canada are some of the factors supporting the market growth in the region. Data released by United States Census Bureau reveals that the total count of Americans aged 65 and above surpassed 49.2 Mn in 2016. Advanced countries in North America have robust health coverage policies along with a quicker access to latest biologic therapeutics. Many market players operating in North America are focusing on patient-centric products. In addition, companies are focusing on delivering customized therapeutics. High healthcare spending in the region is also influencing the market growth. The Center for Disease Control and Prevention reported that healthcare expenditure in the U.S reach to 3.2 trillion in 2015.

Europe in hold the second spot in the global biologic therapy market outlook in terms of revenue. The market in Europe is expected to exhibit a healthy growth over the next couple of years. The healthcare sector remains focused on innovation and continue to excel in delivering quality care. In addition, presence of an advanced healthcare system is reflecting favourably on the market in the region. Many of the advanced countries in Europe have large pool of geriatric population. Data released by Eurostat revealed that more that 19% of the over population in Europe is aged 65 and above.

Asia Pacific is emerging as a highly attractive market for biologic therapy. It is projected that the market in APAC will demonstrate the fastest growth during the forecast period. Increased occurrence of lifestyle diseases is driving the demand for biologic therapy. Rising healthcare expenditure, increased awareness level and improving healthcare infrastructure are some of the key factors influencing the market in APAC.

The market in MEA is expected to witness a relatively slower growth during the forecast period. This is mainly owing low penetration and limited access. However, increased efforts towards improving healthcare standard in GCC countries is likely to create market opportunities.

Global Biologic Therapy Market: Competition Analysis

Global biologic therapy market players include

         ·         Bristol-Myers Squibb,

         ·         Amgen Inc.,

         ·         Eli Lilly,

         ·         Seattle Genetics, Inc.,

         ·         GlaxoSmithKline Plc.,

         ·         Novartis International AG,

         ·         Celgene Corporation and

         ·         Spectrum Pharmaceuticals, Inc.

Global Biologic Therapy Market: Segmental Analysis

MRFR’s report includes a detailed segmental analysis of the market based on therapy, product type, end-user and application. Based on therapy, the market has been segmented into vaccines therapy, cell therapy, protein therapy and others. Based on product type, the market has been segmented into services, instruments and kit and reagents. Based on end-user, the market has been segmented into hospitals and clinic, research centers and speciality centers. Based on application, the market has been segmented into blood and blood-related products testing, tissue and tissue-related products testing, vaccine and therapeutics development, stem cell research and cellular and gene therapy.

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

United States of America

Microbiome Sequencing Services Market Share, Industry Growth Analysis, CAGR Status & Major Key Players

Market Highlights

It is estimated that the global Microbiome Sequencing Services Market Share is expected to register a CAGR ~ 18% during the forecast period of 2023–2032, with an estimated market value of USD 6.70 Billion in 2032.

Numerous factors such as high investment in next-generation sequencing, rising genome mapping programs in various countries, and the demand for microbiome research is anticipated to fuel the growth of the Microbiome Sequencing Services Market. Moreover, the increasing investments in next-generation sequencing by various public and private organizations have created a lucrative option for many companies to invest in providing microbiome sequencing services, leading to the overall growth of the market. For instance, according to the data published by the Wall Street Journal in 2016, reported that venture funding in microbiome firms raised by 458.5% to USD 114.5 million from 2022 to 2030.

Segmentation

The global microbiome sequencing services market outlook has been segmented into technology, application, and end user.

·        The market, based on technology, has been segmented into Sequencing by Litigation (SBL), Sequencing by Synthesis (SBS), short gun sequencing, targeted gene sequencing, RNA sequencing, and others.

·        The market, by application, has been further segmented into gastrointestinal diseases, infectious diseases, CNS diseases, oncology, and others.

·        The market, by end user, has been segmented into research and academic institutes, pharmaceutical and biotechnology companies, and others.

Regional Analysis

The market in the Americas is expected to dominate the global microbiome sequencing services market during the forecast period owing to the increasing per capita healthcare expenditure, and the heavy adoption of new technology in the region. Europe is expected to hold the second largest position in the global microbiome sequencing services market. The market growth in this region is because of the presence of a well-established healthcare system and increase in life-threatening diseases. For instance, according to cancer research UK, there were approximately 9, 921 cases of cancer diagnosed in 2015. Such high rates of cancer are likely to increase demand for use of next-generation sequencing as well as increase the market demands for monoclonal bodies and cellular research. These factors are expected to have a positive impact on the microbiome sequencing services market. Asia-Pacific is estimated to be the fastest growing region in the market due to the huge patient pool of chronic diseases and government initiatives of healthcare reforms. The market in the Middle East & Africa is likely to account for the smallest share of the global microbiome sequencing services market. The market growth in this region owes to the low disposable income in the region.

Key Players

The global microbiome sequencing services market players are

Metabiomics Corp.,

Baseclear B.V.,

Clinical Microbiomics A/S,

EPIBIOME,

Merieux Nutrisciences Corporation,

Microbiome Insights Inc.,

Microbiome Therapeutics, LLC.,

MR DNA,

Rancho Biosciences,

Second Genome,

Ubiome, Inc., and

Zymo Research Corp.

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

United States of America

Portable Ultrasound Bladder Scanner Market: A Roadmap for Success

 

The global portable ultrasound bladder scanner market is segmented by region into North America, Europe, Asia Pacific, and South and Central America. North America and Europe are the major regions in the global market.

North America is the largest market for portable ultrasound bladder scanners, followed by Europe. This is due to a number of factors, including:

• High prevalence of urological disorders, such as urinary tract infections and bladder cancer
• Increasing geriatric population, which is more susceptible to urological disorders
• Well-developed healthcare infrastructure and high healthcare expenditure
• Early adoption of new medical technologies

Subscribe to get Comprehensive Data Insights:

Asia Pacific is expected to be the fastest-growing market for portable ultrasound bladder scanners in the coming years. This is due to a number of factors, including:

• Increasing geriatric population
• Growing prevalence of urological disorders
• Rising disposable incomes
• Increasing healthcare expenditure
• Government initiatives to improve healthcare infrastructure

South and Central America is a relatively small market for portable ultrasound bladder scanners. However, the market is expected to grow in the coming years due to factors such as increasing awareness of urological disorders, rising disposable incomes, and government initiatives to improve healthcare infrastructure.

Here is a more detailed overview of the portable ultrasound bladder scanner market in each region:

North America

North America portable ultrasound bladder scanners market is the largest market for portable ultrasound bladder scanners. The US is the largest market in North America, followed by Canada. The high prevalence of urological disorders, increasing geriatric population, and well-developed healthcare infrastructure in North America are the key factors driving the growth of the portable ultrasound bladder scanner market in the region.

Europe

Europe portable ultrasound bladder scanners market is the second-largest market for portable ultrasound bladder scanners. The UK is the largest market in Europe, followed by Germany and France. The high prevalence of urological disorders, increasing geriatric population, and well-developed healthcare infrastructure in Europe are the key factors driving the growth of the portable ultrasound bladder scanner market in the region.

South and Central America

South and Central America portable ultrasound bladder scanners market is a relatively small market for portable ultrasound bladder scanners. Brazil is the largest market in South and Central America, followed by Mexico and Argentina. The increasing awareness of urological disorders, rising disposable incomes, and government initiatives to improve healthcare infrastructure in South and Central America are the key factors driving the growth of the portable ultrasound bladder scanner market in the region.

Asia Pacific

Asia Pacific portable ultrasound bladder scanners market is the fastest-growing market for portable ultrasound bladder scanners. China is the largest market in Asia Pacific, followed by India and Japan. The increasing geriatric population, growing prevalence of urological disorders, rising disposable incomes, and increasing healthcare expenditure in Asia Pacific are the key factors driving the growth of the portable ultrasound bladder scanner market in the region.

Overall, the global portable ultrasound bladder scanner market is expected to grow at a steady pace in the coming years. The key factors driving the growth of the market include high prevalence of urological disorders, increasing geriatric population, rising disposable incomes, and increasing healthcare expenditure. North America and Europe are the major regions in the global market, while Asia Pacific is expected to be the fastest-growing market in the coming years.

Related Charts:

Argentina Portable Ultrasound Bladder Scanner Market Outlook (2018 to 2032) 

GCC Portable Ultrasound Bladder Scanner Market Outlook (2018 to 2032) 

Turkey Portable Ultrasound Bladder Scanner Market Outlook (2018 to 2032) 

Israel Portable Ultrasound Bladder Scanner Market Outlook (2018 to 2032) 

About Us

Wantstats Research and Media Pvt Ltd is a global market research company that takes pride in its services, offering a complete and accurate analysis with regard to diverse markets and consumers worldwide. WRMPL’s approach combines the proprietary information with various data sources to give an extensive understanding to the client about the latest key developments, expected events and also about what action to take based on these aspects.

Our fast growing industry research firm is backed by a proficient team of research analysts that offers valuable analytics and data with respect to technological and economical advancements. Our deemed analysts perform industrial visits and procure the relevant information from prominent market players. Our key objective is to keep our clients abridged of the potential opportunities and challenges in different markets. We provide step-by-step assistance to our respected clients, via strategic and consulting services to reach a managerial and actionable decision.

Contact Details

Corporate Office (Brazil)

WantStats Research and Media Pvt. Ltd.

Office No 104, Pentagon 4,

Magarpatta City, Pune - 411028

Maharashtra, Brazil.

Sales: +1 (855) 661-4441 (US)   +44 1720 412 167(UK)

Active Pharmaceutical Ingredients Market Report: Regional Data Analysis By Revenue, Price And Gross Margin

 Active Pharmaceutical Ingredients Market Overview

The global active pharmaceutical ingredients market share was valued at USD 277.1 billion in 2021 and is projected to grow from USD 299.21 billion in 2022 to USD 512.13 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 7.98% during the forecast period (2022 - 2030)according to the latest research report from Market Research Future (MRFR). The report studies the market in detail to understand the market’s historical growth trajectory and furthermore makes projections about the market’s likely growth trajectory over the forecast period from 2022 to 2030. Key drivers and restraints affecting the global active pharmaceutical ingredients market are profiled in detail in the report.

Active pharmaceutical ingredients (APIs) are the core of any pharmaceutical formulation and comprise the part of the formulation that actually tackles the respective disease. As a result, active pharmaceutical ingredients are among the most valued and studied components of the pharmaceutical sector and are researched extensively in order to bring about steady drug development in various fields. The growing prevalence of various major diseases has led to a growing demand for new active pharmaceutical ingredients, which is likely to be a major driver for the global Active Pharmaceutical Ingredients Market. Capacity expansion as well as research and development into the development of new APIs are likely to be promising avenues for major players in market over the forecast period. The increasing importance of generics across the healthcare sector is also likely to be a major driver for the market over the forecast period.

The increasing interest in biopharmaceuticals is likely to be a key driver for the market over the forecast period. Due to the increasing interest in biologically based, natural remedies, the biopharmaceuticals market has grown by leaps and bounds. Consumers widely prefer biopharmaceuticals to conventional pharmaceutical products, as the former represent safer formulations with less side effects. This is likely to be a key feature in the market over the forecast period.

Market Segmentation

The global active pharmaceutical ingredients market outlook is segmented on the basis of manufacturing process, type of synthesis, API formulation, application, molecule type, and region.

By manufacturing process, the global active pharmaceutical ingredients market is bifurcated into captive and contract manufacturing.

By type of synthesis, the market is segmented into synthetic and biotech. The biotech synthesis segment is further sub-segmented into monoclonal antibodies, recombinant proteins, vaccines, and others.

By API formulation, the market is segmented into generic and branded/innovative.

By application, the market is segmented into cardiovascular diseases, oncology, neurological disorders, orthopedic disorders, respiratory disorders, gastrointestinal disorders, urology, and others. The cardiovascular disease segment holds the largest share in the market and is likely to remain the leading revenue generator over the forecast period due to the growing demand for effective cardiovascular drug formulations. The growing prevalence of cardiovascular diseases in developed regions is also likely to be a major driver for the segment over the forecast period.

Based on molecule type, the market is segmented into small molecule and large molecule.

Regional Analysis

By region, the active pharmaceutical ingredients market report covers the recent trends and growth opportunities across North America, Europe, the Asia Pacific (APAC), and the Middle East and Africa (MEA). Of these, North America will lead the market during the forecast period for technological advancements, high economic development, and rising incidence of cancer as well as other lifestyle-associated diseases. 

The market in Europe is predicted to hold the second-largest share in the market for the rising initiatives which support the creation of generic drugs. Moreover, favorable reimbursement policies, improving pricing, and huge manufacturing activities are also adding market growth. 

The market in the Asia Pacific region is predicted to develop at a quick pace during the forecast period. The availability of cheap labor and leading companies setting up active pharmaceutical ingredients’ plants in China as well as India are adding to the market growth. 

The market in the MEA is predicted to have a small share during the forecast period. 

Key Players 

Active Pharmaceutical Ingredients Market Players Leading players profiled in the global active pharmaceutical ingredients (API) market report include Teva Pharmaceutical Industries Ltd, Novartis AG, Merck & Co., Inc., GlaxoSmithKline Plc (GSK), Boehringer Ingelheim GmbH, Abbott Laboratories, Sanofi, F. , Pfizer Inc., Eli Lilly and Company, Hoffmann-La Roche AG, and Bayer AG. Industry players have incorporated strategies such as mergers, acquisitions, product launches, and others to stay ahead in the competition. 

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 628 258 0071

Email: sales@marketresearchfuture.com

Negative Pressure Wound Therapy Market Report: Regional Data Analysis By Revenue, Price And Gross Margin

Negative Pressure Wound Therapy Market Highlights:

The negative pressure wound therapy market share was volumed at USD 2.5 billion in 2022 and is expected to rise from USD 2.6 Billion in 2023 to USD 4.16 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 6.1% during the forecast period (2023 - 2032). The report profiles the global negative pressure wound therapy market’s historical statistics to provide reliable insights and predictions into the global negative pressure wound therapy market’s likely growth trajectory over the forecast period. Key players and leading segments in the global negative pressure wound therapy market are also profiled in the report to provide readers with an accurate picture of the market’s inner dynamics.

Negative pressure wound therapy is carried out by covering a wound in a special sealed dressing and exposing it to a vacuum, which draws out pus and other such residue and helps clarify the wound by improving blood circulation in the region. The global negative pressure wound therapy market has mainly grown in the 1990s and 2000s following the development of the method and gradual growth in the awareness about its effectiveness. The growing demand for wound healing systems that promote quick wound healing is expected to be a major driver for the global negative pressure wound therapy market over the forecast period. The clean and non-invasive nature of negative pressure wound therapy is also likely to be a major market driver over the forecast period.

The growing expenditure on wound care is likely to be a key driver for the global negative pressure wound therapy market over the forecast period. Factors such as the growing prevalence of diabetes could also play a crucial role in the global negative pressure wound therapy market over the forecast period, as the therapy is extensively used in the treatment of diabetic ulcers.

Negative Pressure Wound Therapy Market Players

The global negative pressure wound therapy market players include

 Acelity L.P. Inc.,

ConvaTec Group plc,

Smith & Nephew,

Talley Group,

Genadyne,

Molnlycke Health Care AB,

Medela, Lohmann & Rauscher International GmbH & Co. KG,

DeRoyal Industries Inc., and

Cardinal Health.

Segmentation:

The global negative pressure wound therapy market outlook has been segmented on the basis of product type, wound type, end user, and region.

On the basis of product type, the negative pressure wound therapy market has been segmented into conventional negative pressure wound therapy devices, single-use negative pressure wound therapy devices, and accessories. The conventional segment accounted for the largest share of the global market in 2017 due to its effectiveness in handling large volumes of exudates.

By wound type, the global negative pressure wound therapy market is segmented into surgical and traumatic wounds, ulcers, and burns. The ulcers segment has been further subclassified as venous ulcers, foot ulcers, pressure ulcers, and others.

By end use, the global negative pressure wound therapy market is segmented into hospitals, home care settings, and others. Hospitals are likely to remain the leading end user in the global negative pressure wound therapy market over the forecast period due to their prominent role in wound care and the easy availability of advanced negative pressure wound therapy systems in hospitals.

Regional Analysis:

The global negative pressure wound therapy market is segmented into the Americas, Europe, the Middle East and Africa, and Asia Pacific. The Americas segment is expected to dominate the global negative pressure wound therapy market over the forecast period due to the growing demand for wound therapy in the region and the increasing advancement of the healthcare sector, which is facilitating easy access to advanced solutions such as negative pressure wound therapy across the region. According to the National Diabetes Statistics Report, the U.S. housed more than 30.3 million diabetics in 2017. This is likely to be a key driver for the negative pressure wound therapy market in the region over the forecast period.

Europe is also likely to retain a dominant share in the global negative pressure wound therapy market over the forecast period due to the technological advancement of the healthcare sector in the region. Growing prevalence of diabetes could also emerge as a key driver for the negative pressure wound therapy market in Europe over the forecast period.

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

United States of America

Medical Bionic Implant/Artificial Organs Market Report Study, Competitive Strategies and Forecast

Market Overview

Bionic implants are known as artificially engineered devices. These devices are implanted into a human in order to replace a natural organ and to act as a substitute of the same. The global medical bionic implant/artificial organs market share is projected to reach USD 22.17 billion by 2030 at a CAGR of 7.90% over the assessment period between 2022 and 2030.

It is reported that the growing incidences of organ failure to have a positive effect on increasing the demand for replaceable or implantable organs. This is thereby pushing the growth of the overall bionic implant/artificial organs market. The growing aging population is another key factor driving the market demand for these implantable/artificial organs as organ failure is found to be more common in the older age bracket.

A vast number of factors are identified as the potential drivers of the market, such as technological advancements, rising incidences of accidents and injuries, improving regulatory framework, prevalence of organ failure, increasing government support in terms of initiatives and R&D expenditures, and growing prevalence of eye diseases.

However, the high cost associated with the devices, poor healthcare facilities in low and mid-level income nations, and lack of any skilled or proficient professionals can hamper the growth of the market during the forecast period.

Competitive Landscape

The global medical bionic implant artificial organs market players includes the following key players

         ·         Biomet, Inc. (U.S.),

         ·         NeuroPace, Inc. (U.S.),

         ·         Medtronic, Inc. (U.S.),

         ·         Aleva Neurotherapeutics SA (Switzerland),

         ·         Boston Scientific Corporation (U.S.),

         ·         Ekso Bionics (U.S.),

         ·         Cochlear Ltd. (Australia),

         ·         LivaNova PLC (U.K),

         ·         Orthofix International N.V. (The Netherlands),

         ·         Ossur (Iceland),

         ·         Cyberonics, Inc. (U.S.),

         ·         Biocontrol Medical (Israel),

         ·         St. Jude Medical, Inc. (U.S.),

         ·         Second Sight Medical Products, Inc. (U.S.), and others.

Market Segmentation

The global medical bionic implant/artificial organs market overview segmentation is done on the basis of product, technology, fixation, and end-user.

By technology, the market divides into electronic bionics and mechanic bionics.

By fixation, the market is classified into externally worn and implantable.

By end-users, the market includes research and academic institutes, hospitals and clinics, and others.

By product, the market comprises orthopedic bionics, ear bionics, vision bionics, neural/brain bionics, heart bionics, and others.

Here, vision bionics is narrowed down into bionic and others.

Ear bionics is segmented into Bone Anchored Hearing Aid (BAHA) and cochlear implant.

Orthopedic bionics sub-segmented into bionic finger, bionic leg, bionic hand, electrical bone growth stimulators, and exoskeleton. Bionic leg breaks down into bionic feet and bionic knee. Electrical bone growth stimulator segment comprises non-invasive bone growth stimulators and invasive bone growth stimulators.

Heart Bionics segment is divided into total artificial heart, artificial heart valve, pacemaker, and ventricular assist device. The pacemaker segment includes external pacemaker and implantable cardiac pacemaker. Artificial heart valve narrows down into tissue heart valve and mechanical heart valve.

Neural/brain bionics is broken down into vagus nerve stimulators, spinal cord stimulators, and deep brain stimulators.

Regional Analysis

The global medical bionic implant/artificial organs market report is regionally segmented into North America, Europe, Asia Pacific, and the Middle East & Africa region.

The Americas hold the dominant portion of the market due to the emergence of advanced medical bionic implants by various key players.

Europe stands tall as the second largest market in medical bionic implant artificial organs. Herein, favorable government support towards research and development activities and prevalence of organ failure and other relevant complications are expected to be the major drivers of the market.

Asia Pacific is believed to be the fastest growing regional market due to the huge pool of patient population, increasing development in the healthcare technology, and growing demand for advanced form of treatments.

Finally, the Middle East and Africa market holds the lowest share in the global standings due to lack of technical expertise or knowledge, low level of development, and poor medical facilities. The region is expected to grow at a paltry rate.

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

United States of America